Education
About Us
Working with TipRanks
Follow Us
Evogene (EVGN)
NASDAQ:EVGN
Earnings Data
Report Date
Mar 05, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.41Last Year’s EPS
0.06Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
Evogene's earnings call shows a company in transition, focusing on cost reduction and strategic collaborations to leverage its AI technology across pharmaceutical and agriculture sectors. While significant revenue declines were noted, the successful asset sales, reduced losses, and strategic initiatives with prominent partners like Google, Bayer, and Corteva signal a positive future outlook. The sentiment is cautiously optimistic, given the balance between cost savings and revenue challenges.Company Guidance
Significant Cost Reduction
Operating expenses decreased to approximately $2.9 million in Q3 2025 from $6.6 million in the same period of 2024. This new expense level is expected to be maintained going forward.
Income from Asset Sales
The sale of Lavie Bio's assets and the MicroBoost AI for Ag tech-engine to ICL generated income of approximately $7.9 million in Q3 2025.
Operating Loss Reduction
Total operating loss for the first 9 months of 2025 was approximately $8.8 million, compared to $15.3 million in the same period of 2024, mainly due to decreased operating expenses.
Net Income Improvement
The net income for Q3 2025 was approximately $5.2 million, compared to a net loss of $8.2 million in the same period last year.
Successful Strategic Collaborations
Evogene's subsidiary AgPlenus has strategic collaborations with Bayer and Corteva, focusing on developing new herbicides with novel modes of action.
Advancement in AI Technology
ChemPass AI is being enhanced through collaborations, such as the one with Google Cloud, and aims to improve drug and ag-chemical development through advanced multiparameter optimization.
EVGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EVGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 20, 2025 | $1.17 | $1.08 | -7.69% |
Aug 19, 2025 | $1.33 | $1.27 | -4.51% |
May 21, 2025 | $1.27 | $1.18 | -7.09% |
Mar 06, 2025 | $1.41 | $1.41 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Evogene (EVGN) report earnings?
Evogene (EVGN) is schdueled to report earning on Mar 05, 2026, TBA (Confirmed).
What is Evogene (EVGN) earnings time?
Evogene (EVGN) earnings time is at Mar 05, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EVGN EPS forecast?
EVGN EPS forecast for the fiscal quarter 2025 (Q4) is -0.41.